精确诊断和治疗与维生素代谢相关的
Yajing Gan1, Guoyan Li1,2, Zihan Wei1
1Department of Neurology, Epilepsy Center of Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
Acta epileptologica
|April 11, 2025
概括
遗传代谢障碍越来越多地被认为是的原因. 及时补充维生素可以显著改善这些发作疾病的婴儿的结果.
科学领域:
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 遗传学 是一个
背景情况:
- 是一种慢性神经系统疾病,其特征是脑细胞异常排放.
- 发作的原因包括结构性,传染性,代谢性,免疫性和未知的因素.
- 遗传代谢障碍正作为的重要原因受到越来越多的关注.
研究的目的:
- 突出遗传代谢障碍在中的作用.
- 为了强调维生素代谢对发作的影响.
- 强调了解精确治疗策略的代谢基础的重要性.
主要方法:
- 关于遗传代谢障碍和的文献综述.
- 分析将代谢功能障碍与发作联系在一起的机制 (例如,能量缺乏,毒性积累).
- 检查特定维生素 (胺,生物素,B6,B12,叶酸) 在病因学中的作用.
主要成果:
- 超过200种遗传代谢障碍与发作有关.
- 机制包括大脑能量缺陷,有毒物质积累,神经递质失衡和辅助因子缺乏.
- 关键维生素的代谢受损会导致早期发作和发育问题.
结论:
- 遗传代谢障碍是的重要,可治疗的原因.
- 及时的维生素补充治疗可以大大改善患者的预后.
- 研究的代谢基础对于开发有针对性和有效的治疗方法至关重要.
相关概念视频
Arteries of the Lower Limbs
168
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
168
Antiepileptic Drugs: Glutamate Antagonists
252
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
252
Inborn Errors of Metabolism
114
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
114
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
190
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
190
Seizures: Classification
285
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
285
Electroconvulsive Therapy
18
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
18


